LSDs mainly affect children in their first decade of life.
By developing an experimental plan to understand the basis, the natural history and to test potential therapies, the EUCLYD consortium will provide an enormous impact on the health of children who are being devastated by this type of progressive, debilitating and often lethal group of disorders.